Deepak Gondaliya
Corporate Officer/Principal bei Emcure Pharmaceuticals Ltd.
Aktive Positionen von Deepak Gondaliya
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01.07.2013 | - |
Karriereverlauf von Deepak Gondaliya
Ehemalige bekannte Positionen von Deepak Gondaliya
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | - | - |
Ausbildung von Deepak Gondaliya
Hemchandracharya North Gujarat University | Doctorate Degree |
Statistik
International
Indien | 4 |
Operativ
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Börse
- Insiders
- Deepak Gondaliya
- Erfahrung